Tuberous Sclerosis Complex

CBD-Based Life-Changing Drug For Tuberous Sclerosis Patients, Epidiolex, Now Available Via England's NHS

The National Health Service England confirmed Tuesday that starting this week, doctors can prescribe Jazz Pharmaceuticals (NASDAQ: JAZZ) Epidiolex, a CBD-based medicine, to patients suffering from tuberous sclerosis complex (TSC). This mea

Marinus' Oral Ganaxolone Lowers Seizure Frequency In Genetic Disorder

Marinus Pharmaceuticals Inc (NASDAQ: MRNS) announced topline data from its open-label Phase 2 trial evaluating oral ganaxolone in patients with seizures associated with tuberous sclerosis complex (TSC).